tradingkey.logo
tradingkey.logo
Search

DiaMedica Therapeutics Inc

DMAC
Add to Watchlist
6.550USD
+0.080+1.24%
Close 09-11 16:00ET
353.21MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.24%

5 Days

-2.96%

1 Month

-2.96%

6 Months

-10.03%

Year to Date

-17.71%

1 Year

-7.62%

Key Figures

6.490Open
6.630High
10.72KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
6.470Prev. Close
6.500Low
70.36KTurnover
LossP/E Static
9.21P/B
0.00%Div Yield TTM
-76.38%ROA
10.42052wk High
0.07Volume Ratio
-24.44MNet Profit
53.93MShares
-0.7042EPS TTM
1.15Beta
-86.47%ROE
5.24552wk Low
2.01%Amplitude
--Gross Margin
353.21MMarket Cap
-1.41Reward/Risk
3.48%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

DiaMedica Therapeutics Inc's Score

-0.14vs previous score
Forecast8.00
Financial Health5.46
Technical3.00
Valuation Dimensions7.37
Institutional Confidence3.00
Risk Assessment4.92

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
17.000Target Price
+162.75%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy55555555
Hold00000000
Sell00000000
Strong Sell00000000

DiaMedica Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Neutral

Moving Average

Neutral

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.19/-0.20
Revenue / Forecast
--/0.00

DiaMedica Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolDMAC
Number of employees27
CountryUnited States of America

Ownership

ShareholdersProportion
Trill AB,LLC.16.38%
EQT Partners AB15.56%
Jacinto (Richard II)9.20%
Omega Advisors, Inc.3.75%
Shareholder TypesProportion
Corporation16.38%
Private Equity15.56%
Individual Investor11.36%
Investment Advisor9.90%

FAQs

What is the current price of DiaMedica Therapeutics Inc (DMAC)?

The current price of DiaMedica Therapeutics Inc (DMAC) is 6.47.

What is the symbol of DiaMedica Therapeutics Inc?

The ticker symbol of DiaMedica Therapeutics Inc is DMAC.

What is the 52-week high of DiaMedica Therapeutics Inc?

The 52-week high of DiaMedica Therapeutics Inc is 10.42.

What is the 52-week low of DiaMedica Therapeutics Inc?

The 52-week low of DiaMedica Therapeutics Inc is 5.25.

What is the market capitalization of DiaMedica Therapeutics Inc?

The market capitalization of DiaMedica Therapeutics Inc is 349.44M.

Is DiaMedica Therapeutics Inc (DMAC) currently rated as Buy, Hold, or Sell?

According to analysts, DiaMedica Therapeutics Inc (DMAC) has an overall rating of Buy, with a price target of 17.00.

What is the Earnings Per Share (EPS TTM) of DiaMedica Therapeutics Inc (DMAC)?

The Earnings Per Share (EPS TTM) of DiaMedica Therapeutics Inc (DMAC) is -0.70.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.